Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)Hiroshi Nokihara, Tomohide Tamura, Shun Lü et al.|Annals of Oncology|2017Cited by 97
A phase II trial of afatinib (BIBW 2992) in patients (pts) with advanced non-small cell lung cancer previously treated with erlotinib (E) or gefitinib (G).Nobuyuki Yamamoto, Maryam Shahidi, A. Inoue et al.|Journal of Clinical Oncology|2011Cited by 25
EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel in patients with non-small-cell lung cancer who had received a platinum-based treatmentMakoto Nishio, Tomohide Tamura, Tony Mok et al.|Annals of Oncology|2016Cited by 10